Reuters logo
BRIEF-Revenio starts to commercialize technology for screening, diagnosis and monitoring of asthma
February 2, 2015 / 7:12 AM / in 3 years

BRIEF-Revenio starts to commercialize technology for screening, diagnosis and monitoring of asthma

Feb 2 (Reuters) - Revenio Group Oyj :

* Has begun to commercialize technology for the screening, diagnosis and monitoring of asthma

* Has signed a license agreement with Tide Medical Oy concerning a patented invention relating to diagnosis of asthma

* Current outlook indicates that it will take several years before these products become commercially significant for company

* Asthma is one of most common chronic diseases in world with over 300 million sufferers Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below